Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Placebo-controlled Randomized Clinical Trial: tDCS to Prevent Relapse in Alcohol Use Disorder

NCT04990375 is registered in ClinicalTrials.gov with Brugmann University Hospital as lead sponsor.

NCT NCT04990375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04990375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Placebo-controlled Randomized Clinical Trial: tDCS to Prevent Relapse in Alcohol Use Disorder
Lead sponsor
Brugmann University Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 2, 2021
Completion date
June 6, 2022
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

active tdcs, sham tdcs